Biomarin Pharmaceutical Inc
BMRN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001048477
In the last 90 days, Biomarin Pharmaceutical Inc insiders filed 0 open-market purchases and 1 sale; 565 institutions reported holding it in 13F filings for Q2 2026, worth $11.1B in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q1 2021
Institutional positions in Biomarin Pharmaceutical Inc as of Mar 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 532
- No complete 13F data for Q4 2020
- Shares held
- 178.3M
- No complete 13F data for Q4 2020
- Total value
- $13.5B
- No complete 13F data for Q4 2020
Holders and value by quarter
Institutions reporting BMRN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 565 | $11.1B |
| Q1 2026 | 559 | $10.4B |
| Q4 2025 | 539 | $11.2B |
| Q3 2025 | 577 | $9.72B |
| Q2 2025 | 582 | $10.1B |
| Q1 2025 | 584 | $13.0B |
| Q4 2024 | 544 | $12.0B |
| Q3 2024 | 556 | $12.7B |
| Q2 2024 | 561 | $15.2B |
| Q1 2024 | 560 | $16.3B |
| Q4 2023 | 549 | $17.9B |
| Q3 2023 | 521 | $16.1B |
| Q2 2023 | 559 | $15.5B |
| Q1 2023 | 554 | $17.4B |
| Q4 2022 | 581 | $18.9B |
| Q3 2022 | 552 | $15.5B |
| Q2 2022 | 544 | $14.8B |
| Q1 2022 | 560 | $13.7B |
| Q4 2021 | 557 | $15.7B |
| Q3 2021 | 514 | $13.6B |
| Q2 2021 | 531 | $14.7B |
| Q1 2021 | 532 | $13.5B |
Institutions, Q1 2021
Shares, value and share of portfolio for each institution holding Biomarin Pharmaceutical Inc.
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| California Public Employees Retirement System | 922,713 | $69.7M | 0.05% | – | – |
| Davide Leone & Partners Investment Co Ltd. | 964,669 | $72.8M | 9.77% | – | – |
| Legal & General Group Plc | 1,091,786 | $82.4M | 0.03% | – | – |
| First Trust Advisors LP | 1,129,661 | $85.3M | 0.10% | – | – |
| Deutsche Bank AG | 1,138,091 | $85.9M | 0.05% | – | – |
| Natixis | 1,154,619 | $87.2M | 0.29% | – | – |
| Goldman Sachs Group Inc | 1,212,842 | $91.6M | 0.03% | – | – |
| Northern Trust Corp | 1,214,996 | $91.7M | 0.02% | – | – |
| Nuveen Asset Management, LLC | 1,423,664 | $107.5M | 0.03% | – | – |
| Pictet Asset Management Ltd | 1,565,213 | $118.2M | 0.14% | – | – |
| Citadel Advisors LLC | 1,633,680 | $123.4M | 0.13% | – | – |
| Avoro Capital Advisors LLC | 1,650,000 | $124.6M | 2.15% | – | – |
| Manning & Napier Group, LLC | 1,704,842 | $128.7M | 1.09% | – | – |
| Bank of America Corp | 1,867,319 | $141.0M | 0.02% | – | – |
| Price T Rowe Associates Inc | 1,910,510 | $144.3M | 0.01% | – | – |
| Geode Capital Management, LLC | 2,168,045 | $163.5M | 0.03% | – | – |
| Norges Bank | 2,194,319 | $165.7M | 0.04% | – | – |
| Palo Alto Investors LP | 2,205,750 | $166.6M | 9.49% | – | – |
| UBS Asset Management Americas Inc | 2,238,061 | $169.0M | 0.07% | – | – |
| Parnassus Investments | 2,684,874 | $202.7M | 0.49% | – | – |
| JPMorgan Chase & Co | 2,835,612 | $214.1M | 0.03% | – | – |
| State Street Corp | 4,674,402 | $353.0M | 0.02% | – | – |
| Janus Henderson Group PLC | 4,993,655 | $377.1M | 0.17% | – | – |
| Clearbridge Investments, LLC | 5,003,970 | $377.9M | 0.28% | – | – |
| Ameriprise Financial Inc | 6,233,335 | $470.7M | 0.16% | – | – |
| Baker Bros. Advisors LP | 7,589,294 | $573.1M | 2.48% | – | – |
| Dodge & Cox | 11,854,308 | $895.1M | 0.64% | – | – |
| BlackRock Inc. | 13,934,157 | $1.05B | 0.03% | – | – |
| Vanguard Group Inc | 16,354,349 | $1.23B | 0.03% | – | – |
| Primecap Management Co | 18,157,794 | $1.37B | 0.96% | – | – |
| Capital Research Global Investors | 22,076,365 | $1.67B | 0.41% | – | – |
| Westside Investment Management, Inc. | 3,870 | – | – | – | – |